相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of erythropoietin on fibroblast growth factor 23 in mice and humans
Mark R. Hanudel et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2019)
Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia
Rafiou Agoro et al.
FASEB JOURNAL (2018)
Oral Versus Intravenous Iron Supplementation for the Treatment of Iron Deficiency Anemia in Patients on Maintenance Hemodialysis-Effect on Fibroblast Growth Factor-23 Metabolism
Wataru Fukao et al.
JOURNAL OF RENAL NUTRITION (2018)
Erythropoietin induces bone marrow and plasma fibroblast growth factor 23 during acute kidney injury
Luis Toro et al.
KIDNEY INTERNATIONAL (2018)
Burosumab Therapy in Children with X-Linked Hypophosphatemia
Thomas O. Carpenter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Erythropoietin stimulates fibroblast growth factor 23 (FGF23) in mice and men
Arezoo Daryadel et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2018)
Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat model
Hidekazu Sugiura et al.
PLOS ONE (2018)
Targeting Fibroblast Growth Factor 23 Signaling with Antibodies and Inhibitors, Is There a Rationale?
Seiji Fukumoto
FRONTIERS IN ENDOCRINOLOGY (2018)
α-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling
Gaozhi Chen et al.
NATURE (2018)
Acute blood loss stimulates fibroblast growth factor 23 production
Seham Rabadi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2018)
Randomized trial of intravenous iron-induced hypophosphatemia
Myles Wolf et al.
JCI INSIGHT (2018)
Fibroblast Growth Factor 23 and the Risk of Infection-Related Hospitalization in Older Adults
Kristen L. Nowak et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Spleen contributes significantly to increased circulating levels of fibroblast growth factor 23 in response to lipopolysaccharide-induced inflammation
Shweta Bansal et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Long-term iron polymaltose infusions associated with hypophosphataemic osteomalacia: a report of two cases and review of the literature
Ramy H. Bishay et al.
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2017)
Intact FGF23 and -klotho during acute inflammation/sepsis in CKD patients
Evangelia Dounousi et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2017)
Erythropoietin stimulates murine and human fibroblast growth factor-23, revealing novel roles for bone and bone marrow
Erica L. Clinkenbeard et al.
HAEMATOLOGICA (2017)
C-Terminal Fibroblast Growth Factor 23, Iron Deficiency, and Mortality in Renal Transplant Recipients
Michele F. Eisenga et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
FGF23 is synthesised locally by renal tubules and activates injury-primed fibroblasts
Edward R. Smith et al.
SCIENTIFIC REPORTS (2017)
Erythropoietin stimulates murine and human fibroblast growth factor-23, revealing novel roles for bone and bone marrow
Erica L. Clinkenbeard et al.
HAEMATOLOGICA (2017)
High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients
Hirokazu Honda et al.
PLOS ONE (2017)
FGF23 expression in rodents is directly induced via erythropoietin after inhibition of hypoxia inducible factor proline hydroxylase
Ingo Flamme et al.
PLOS ONE (2017)
Low serum iron is associated with high serum intact FGF23 in elderly men: The Swedish MrOS study
Catharina Lewerin et al.
BONE (2017)
Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease
Maren Leifheit-Nestler et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2016)
Serum fibroblast growth factor 23, serum iron and bone mineral density in premenopausal women
Erik A. Imel et al.
BONE (2016)
Fibroblast growth factor 23 in acute burn patients: Novel insights from an intact-form assay
Anne-Francoise Rousseau et al.
BURNS (2016)
Serum Fibroblast Growth Factor 23 (FGF23) in Patients with Rheumatoid Arthritis
Hiroe Sato et al.
INTERNAL MEDICINE (2016)
Cord Blood Ferritin and Fibroblast Growth Factor-23 Levels in Neonates
Farah N. Ali et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
CYP24 inhibition as a therapeutic target in FGF23-mediated renal phosphate wasting disorders
Xiuying Bai et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
C-Terminal to Intact Fibroblast Growth Factor 23 Ratio in Relation to Estimated Glomerular Filtration Rate in Elderly Population
Maria Bozentowicz-Wikarek et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2016)
Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production
Valentin David et al.
KIDNEY INTERNATIONAL (2016)
Update on FGF23 and Klotho signaling
Reinhold G. Erben
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2016)
Klotho modulates FGF23-mediated NO synthesis and oxidative stress in human coronary artery endothelial cells
Beatrice Richter et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2016)
Effects of intravenous iron on fibroblast growth factor 23 (FGF23) in haemodialysis patients: a randomized controlled trial
Matthew A. Roberts et al.
BMC Nephrology (2016)
Excessive Osteocytic Fgf23 Secretion Contributes to Pyrophosphate Accumulation and Mineralization Defect in Hyp Mice
Sathish K. Murali et al.
PLOS BIOLOGY (2016)
Effects of dietary iron intake and chronic kidney disease on fibroblast growth factor 23 metabolism in wild-type and hepcidin knockout mice
Mark R. Hanudel et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2016)
The hypoxia-inducible factor-1α activates ectopic production of fibroblast growth factor 23 in tumor-induced osteomalacia
Qian Zhang et al.
Bone Research (2016)
Inflammation but not obesity or insulin resistance is associated with increased plasma fibroblast growth factor 23 concentration in the elderly
Michal Holecki et al.
CLINICAL ENDOCRINOLOGY (2015)
Membrane and Integrative Nuclear Fibroblastic Growth Factor Receptor (FGFR) Regulation of FGF-23
Xiaobin Han et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Iron Supplementation Associated With Loss of Phenotype in Autosomal Dominant Hypophosphatemic Rickets
Klaus Kapelari et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
FGF23 gene regulation by 1,25-dihydroxyvitamin D: opposing effects in adipocytes and osteocytes
Ichiro Kaneko et al.
JOURNAL OF ENDOCRINOLOGY (2015)
Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli
Nobuaki Ito et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
Fibroblast growth factor is associated to left ventricular mass index, anemia and low values of transferrin saturation
Baris Eser et al.
NEFROLOGIA (2015)
Potential Predictors of Plasma Fibroblast Growth Factor 23 Concentrations: Cross-Sectional Analysis in the EPIC-Germany Study
Romina di Giuseppe et al.
PLOS ONE (2015)
Interleukin-1-induced acute bone resorption facilitates the secretion of fibroblast growth factor 23 into the circulation
Miwa Yamazaki et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2015)
Associations of Fibroblast Growth Factor-23 with Markers of Inflammation, Insulin Resistance and Obesity in Adults
Lynae J. Hanks et al.
PLOS ONE (2015)
A systematic analysis of global anemia burden from 1990 to 2010
Nicholas J. Kassebaum et al.
BLOOD (2014)
Disordered FGF23 and Mineral Metabolism in Children with CKD
Anthony A. Portale et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease
Myles Wolf et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2014)
Genetic Rescue of Glycosylation-deficient Fgf23 in the Galnt3 Knockout Mouse
Shoji Ichikawa et al.
ENDOCRINOLOGY (2014)
FGF-23 Is a Negative Regulator of Prenatal and Postnatal Erythropoiesis*
Lindsay M. Coe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Neonatal Iron Deficiency Causes Abnormal Phosphate Metabolism by Elevating FGF23 in Normal and ADHR Mice
Erica L. Clinkenbeard et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Insulin resistance is associated with Fibroblast Growth Factor-23 in stage 3-5 chronic kidney disease patients
Jocelyn S. Garland et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2014)
Fibroblast Growth Factor-23 and Cardiovascular Events in CKD
Julia J. Scialla et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
The Kidney Is the Principal Organ Mediating Klotho Effects
Karolina Lindberg et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Molecular interactions of FGF23 and PTH in phosphate regulation
Beate Lanske et al.
KIDNEY INTERNATIONAL (2014)
Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription
Tomer Meir et al.
KIDNEY INTERNATIONAL (2014)
FGF23 protein expression in coronary arteries is associated with impaired kidney function
Natalie A. van Venrooij et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis
Vincent S. Tagliabracci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Predictors of intact and C-terminal fibroblast growth factor 23 in Gambian children
Vickie Braithwaite et al.
ENDOCRINE CONNECTIONS (2014)
Regulation of erythropoiesis by hypoxia-inducible factors
Volker H. Haase
BLOOD REVIEWS (2013)
Molecular Mechanisms of Vitamin D Action
Mark R. Haussler et al.
CALCIFIED TISSUE INTERNATIONAL (2013)
The effects of iron on FGF23-mediated Ca-P metabolism in CKD patients
Serpil Muge Deger et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2013)
Effects of Dietary Phosphate Restriction and Phosphate Binders on FGF23 Levels in CKD
Tamara Isakova et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Calcium Regulates FGF-23 Expression in Bone
Valentin David et al.
ENDOCRINOLOGY (2013)
Nuclear Fibroblast Growth Factor 2 (FGF2) Isoforms Inhibit Bone Marrow Stromal Cell Mineralization Through FGF23/FGFR/MAPK In Vitro
Liping Xiao et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Exome sequencing reveals FAM20c mutations associated with fibroblast growth factor 23-related hypophosphatemia, dental anomalies, and ectopic calcification
Silje Hjorth Rafaelsen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women
Myles Wolf et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Plasma FGF23 levels increase rapidly after acute kidney injury
Marta Christov et al.
KIDNEY INTERNATIONAL (2013)
Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease
Kathleen M. Hill et al.
KIDNEY INTERNATIONAL (2013)
FGF-23 and secondary hyperparathyroidism in chronic kidney disease
Justin Silver et al.
NATURE REVIEWS NEPHROLOGY (2013)
Effect of ferric carboxymaltose on serum phosphate and C-terminal FGF23 levels in non-dialysis chronic kidney disease patients: post-hoc analysis of a prospective study
Merche Prats et al.
BMC NEPHROLOGY (2013)
High dose intravenous iron, mineral homeostasis and intact FGF23 in normal and uremic rats
Eva Gravesen et al.
BMC NEPHROLOGY (2013)
Fibroblast growth factor 23 contributes to diminished bone mineral density in childhood inflammatory bowel disease
Mostafa Abdel-Aziz El-Hodhod et al.
BMC GASTROENTEROLOGY (2012)
Fibroblast Growth Factor 23 and Inflammation in CKD
Fair Aunoz Mendoza et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Fibroblast Growth Factor 23-Related Osteomalacia Caused by the Prolonged Administration of Saccharated Ferric Oxide
Sunao Yamamoto et al.
INTERNAL MEDICINE (2012)
Biological Variability of Plasma Intact and C-Terminal FGF23 Measurements
Edward R. Smith et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Circulating αKlotho influences phosphate handling by controlling FGF23 production
Rosamund C. Smith et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Calcium Deficiency Reduces Circulating Levels of FGF23
Maria E. Rodriguez-Ortiz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Update on fibroblast growth factor 23 in chronic kidney disease
Myles Wolf
KIDNEY INTERNATIONAL (2012)
Residual renal function is an independent determinant of serum FGF-23 levels in dialysis patients
Liesbeth Viaene et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Inactivation of a Novel FGF23 Regulator, FAM20C, Leads to Hypophosphatemic Rickets in Mice
Xiaofang Wang et al.
PLOS GENETICS (2012)
FGF23 is correlated with iron status but not with inflammation and decreases after iron supplementation: a supplementation study
Vickie Braithwaite et al.
INTERNATIONAL JOURNAL OF PEDIATRIC ENDOCRINOLOGY (2012)
Effect of Intravenous Saccharated Ferric Oxide on Serum FGF23 and Mineral Metabolism in Hemodialysis Patients
Yoko Takeda et al.
AMERICAN JOURNAL OF NEPHROLOGY (2011)
PTH Ablation Ameliorates the Anomalies of Fgf23-Deficient Mice by Suppressing the Elevated Vitamin D and Calcium Levels
Quan Yuan et al.
ENDOCRINOLOGY (2011)
Novel mutations in GALNT3 causing hyperphosphatemic familial tumoral calcinosis
Alan Yancovitch et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2011)
Iron Modifies Plasma FGF23 Differently in Autosomal Dominant Hypophosphatemic Rickets and Healthy Humans
Erik A. Imel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
Tamara Isakova et al.
KIDNEY INTERNATIONAL (2011)
Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice
Emily G. Farrow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Circulating Fibroblast Growth Factor 23 in Patients with End-Stage Renal Disease Treated by Peritoneal Dialysis Is Intact and Biologically Active
Takashi Shimada et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
FGF23 or PTH: which comes first in CKD?
Tamara Isakova et al.
KIDNEY INTERNATIONAL (2010)
Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease
Hisashi Hasegawa et al.
KIDNEY INTERNATIONAL (2010)
Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease
P. Manghat et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation
Regina Goetz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop
Vardit Lavi-Moshayoff et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Hypophosphatemia induced by intravenous administration of saccharated ferric oxide Another form of FGF23-related hypophosphatemia
Yuichiro Shimizu et al.
BONE (2009)
Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model
Teruyo Nakatani et al.
FASEB JOURNAL (2009)
Defective O-Glycosylation due to a Novel Homozygous S129P Mutation Is Associated with Lack of Fibroblast Growth Factor 23 Secretion and Tumoral Calcinosis
Clemens Bergwitz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
FGF23 Elevation and Hypophosphatemia after Intravenous Iron Polymaltose: A Prospective Study
Belinda J. Schouten et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005
Erin McLean et al.
PUBLIC HEALTH NUTRITION (2009)
FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1
Jyothsna Gattineni et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Fibroblast growth factor-23 regulates parathyroid hormone and 1α-hydroxylase expression in cultured bovine parathyroid cells
Tijana Krajisnik et al.
JOURNAL OF ENDOCRINOLOGY (2007)
Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism
Takehisa Kawata et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
The association of circulating ferritin with serum concentrations of fibroblast growth factor-23 measured by three commercial assays
Brian H. Durham et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2007)
Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice
Jason R. Stubbs et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
1,25-dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism
Thomas K. Barthel et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
Mineralized tissue cells are a principal source of FGF23
Yuji Yoshiko et al.
BONE (2007)
Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women
Sherri-Ann M. Burnett et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis - Secretion of fibroblast growth factor 23 requires O-glycosylation
Kentaro Kato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Pathogenic role of Fgf23 in Hyp mice
Shiguang Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D
Shiguang Liu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia
Erik A. Imel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
1α,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone:: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport
OI Kolek et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2005)
Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism
T Shimada et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease
O Gutierrez et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Genetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations
XJ Yu et al.
BONE (2005)
Circulating FGF-23 is regulated by 1α,25-dihydroxyvitamin D3 and phosphorus in vivo
H Saito et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency
T Shigematsu et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
Molecular biology of erythropoietin
W Jelkmann
INTERNAL MEDICINE (2004)
Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice
D Sitara et al.
MATRIX BIOLOGY (2004)
Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX
SG Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Serum FGF23 levels in normal and disordered phosphorus homeostasis
TJ Weber et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
KB Jonsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers
T Larsson et al.
KIDNEY INTERNATIONAL (2003)
Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia
Y Yamazaki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23
KE White et al.
KIDNEY INTERNATIONAL (2001)
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
T Shimada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
KE White et al.
NATURE GENETICS (2000)
Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain
T Yamashita et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
分享论文
